The Accelerating Rare Disease Cures (ARC) program is intended to be an umbrella that coordinate rare disease activities in CDER. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
